Clinical Trials in Philadelphia

Showing 3301-3320 of 17,926 trials

A Study of LY3405105 in Participants With Advanced Cancer

NCT03770494

The main purpose of this study is to investigate the safety of LY3405105 in participants with advanced cancer. The study has two parts phase 1a and phase 1b. Participants will only enroll in one part.

Solid Tumor

Eli Lilly and Company54 participantsStarted Jan 2019

Fayetteville, Arkansas, United States • New Haven, Connecticut, United States • New York, New York, United States +14 more locations

TERMINATEDPhase 3< 1 mile

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

NCT05964413

A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate efficacy and safety of vilobelimab in the treatment of ulcerative pyoderma gangrenosum

Pyoderma Gangrenosum

InflaRx GmbH54 participantsStarted Nov 2023

Hialeah, Florida, United States • Miami, Florida, United States • Orlando, Florida, United States +47 more locations

A Study of LY3405105 in Participants With Advanced Cancer

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

Find Trials by Condition in Philadelphia

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Rutgers University Study of the Genetics of Kidney Disease

DECIDE to Improve Maternal Mental Health Care Delivery

A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

ZILRETTA in Subjects With Shoulder Osteoarthritis

Post-Market Study to Assess iTind Safety in Comparison to UroLift

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease